Search - tctmd.com

$TCT-50. Influence of Age on Clinical Outcomes in Patients with NSTEMI Undergoing Treatment with Abciximab plus Unfractionated Heparin vs. Bivalirudin: Analysis of the ISAR...$

Presentation TCT 2012

TCT-50. Influence of Age on Clinical Outcomes in Patients with NSTEMI Undergoing Treatment with Abciximab plus Unfractionated Heparin vs. Bivalirudin: Analysis of the ISAR...

Presenter: Lamin King

October 23, 2012

News Conference News TCT 2012

PARADOX: Smoking Enhances Effect of Clopidogrel, Prasugrel Unaffected by Smoking Status

October 23, 2012

News Conference News TCT 2012

Review of TAVR Use Offers Significant Advances, Positive Outcomes

October 22, 2012

Advertisement

Extended Dual Antiplatelet Therapy Lowers Death, MI Rates in DES Patients

Prasugrel, Ticagrelor Show Delayed Action in STEMI Patients

Meta-analysis Questions Benefit of Longer Dual Antiplatelet Therapy Post-PCI

Meta-análisis cuestiona beneficio de la terapia antiplaquetaria doble extendida después la PCI

Bivalirudin Shows Advantage Over GPIs—But Not Heparin Alone—in STEMI Patients

Meta-analysis: Clinical Impact of Extended DAPT After PCI in the DES Era

Study Shows Impact of Public Health Communication on Clopidogrel Use Post DES

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

Evidence Continues to Support Dabigatran Treatment in A-fib

No Mortality Benefit with Prolonged Dual Antiplatelet Therapy

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

Aspirin, Cilostazol Combination Best After Angioplasty for Critical Limb Ischemia

The Interventional Pharmacotherapy Legacy: Facilitating and Transforming Clinical Outcomes

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

Elixir Medical Corporation Announces Outstanding Three-Year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System

Elixir Medical Corporation Announces Outstanding Three-year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System(2)

TCT-56. Incremental Value of Platelet Reactivity Over a Risk Score of Clinical and Procedural Variables in Predicting Bleeding Events After Percutaneous Coronary Intervention

TCT-50. Influence of Age on Clinical Outcomes in Patients with NSTEMI Undergoing Treatment with Abciximab plus Unfractionated Heparin vs. Bivalirudin: Analysis of the ISAR...

PARADOX: Smoking Enhances Effect of Clopidogrel, Prasugrel Unaffected by Smoking Status

Review of TAVR Use Offers Significant Advances, Positive Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content